Determination of output factors for small proton therapy fields
Authors:
- Jonas D. FontenotJFJonas D. Fontenot
- Wayne D. NewhauserWNWayne D. Newhauser
- Charles BlochCBCharles Bloch
- R. Allen WhiteRWR. Allen White
- Uwe TittUTUwe Titt
- George StarkschallGSGeorge Starkschall
- 17 January 2007
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 34 (2) , 489-498
Abstract
Current protocols for the measurement of proton dose focus on measurements under reference conditions; methods for measuring dose under patient-specific conditions have not been standardized. In particular, it is unclear whether dose in patient-specific fields can be determined more reliably with or without the presence of the patient-specific range compensator. The aim of this study was to quantitatively assess the reliability of two methods for measuring dose per monitor unit (DIMU) values for small-field treatment portals: one with the range compensator and one without the range compensator. A Monte Carlo model of the Proton Therapy Center-Houston double-scattering nozzle was created, and estimates of D/MU values were obtained from 14 simulated treatments of a simple geometric patient model. Field-specific D/MU calibration measurements were simulated with a dosimeter in a water phantom with and without the range compensator. D/MU values from the simulated calibration measurements were compared with D/MU values from the corresponding treatment simulation in the patient model. To evaluate the reliability of the calibration measurements, six metrics and four figures of merit were defined to characterize accuracy, uncertainty, the standard deviations of accuracy and uncertainty, worst agreement, and maximum uncertainty. Measuring D/MU without the range compensator provided superior results for five of the six metrics and for all four figures of merit. The two techniques yielded different results primarily because of high-dose gradient regions introduced into the water phantom when the range compensator was present. Estimated uncertainties (approximately 1 mm) in the position of the dosimeter in these regions resulted in large uncertainties and high variability in D/MU values. When the range compensator was absent, these gradients were minimized and D/MU values were less sensitive to dosimeter positioning errors. We conclude that measuring D/MU without the range compensator present provides more reliable results than measuring it with the range compensator in place.Keywords
This publication has 19 references indexed in Scilit:
- The prediction of output factors for spread-out proton Bragg peak fields in clinical practicePhysics in Medicine & Biology, 2005
- Calculations of neutron dose equivalent exposures from range-modulated proton therapy beamsPhysics in Medicine & Biology, 2005
- Uveal Melanoma: Proton Beam IrradiationOphthalmology Clinics of North America, 2005
- Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59Medical Physics, 2002
- Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons aloneInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Code of practice for clinical proton dosimetryRadiotherapy and Oncology, 1991
- Compensating for heterogeneities in proton radiation therapyPhysics in Medicine & Biology, 1984
- Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spineJournal of Neurosurgery, 1982
- Compensation for inhomogeneities in charged particle radiotherapy using computed tomographyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1978
- Proton penetration and control in nonhomogeneous phantomsMedical Physics, 1977